PATENT CLAIM ANALYSIS

Application Number: 15891785
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
Methods of treating a seizure disorder with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid, or (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid (KT-II-115), or a pharmaceutically acceptable salt of any of the preceding, are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of a seizure disorder. Methods of treating Prader-Willi syndrome with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid, or (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid (KT-II-115), or a pharmaceutically acceptable salt of any of the preceding, are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of Prader-Willi syndrome.

Claim (Index 14):
The method of treating a seizure disorder according to  claim 9 , wherein the subject has been diagnosed with infantile spasms and the method provides improvement in at least one symptom selected from the group consisting of seizures, cognitive impairment, developmental regression and hypsarrhythmia.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 88.0
- Lexical Diversity: 2.84444
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15680417', '15586730', '13581187', '15289480', '12666703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8126133057079914
- 35 USC 102 Novelty (BERT): 0.536171499132826
- Combined Prediction Score: 0.7849691250504749
- Mean Citation Score: 290.8644500000001
- Max Citation Score: 381.6023
- Similarity Product: 243.06741388792992

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test